These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 14633992)

  • 1. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
    Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
    EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
    Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
    Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
    Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
    Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
    Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
    Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
    Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
    Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
    Ohki I; Shimotake N; Fujita N; Nakao M; Shirakawa M
    EMBO J; 1999 Dec; 18(23):6653-61. PubMed ID: 10581239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
    Koch C; Strätling WH
    Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromatin-immunopurified MeCP2-associated fragments.
    El-Osta A; Wolffe AP
    Biochem Biophys Res Commun; 2001 Dec; 289(3):733-7. PubMed ID: 11726209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support.
    Shiraishi M; Sekiguchi A; Chuu YH; Sekiya T
    Biol Chem; 1999 Sep; 380(9):1127-31. PubMed ID: 10543452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
    Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
    Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island.
    Koizume S; Tachibana K; Shiraishi M
    Biol Chem; 2003 May; 384(5):787-90. PubMed ID: 12817475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-CpG binding proteins in the nervous system.
    Fan G; Hutnick L
    Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.
    Wade PA
    Oncogene; 2001 May; 20(24):3166-73. PubMed ID: 11420733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.